Navigation Links
Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
Date:7/7/2008

.

Angiotech's obligation to accept for payment and to pay for Notes validly tendered and not withdrawn pursuant to the tender offer is conditioned upon (a) the Minimum Tender Condition, (b) the consummation of the concurrently announced investment in API which requires approval from Angiotech's shareholders and (c) satisfaction of certain general conditions.

Cautionary Statement Regarding Forward-Looking Statements

---------------------------------------------------------

Statements contained in this press release that are not based on historical fact, including without limitation statements containing the words "believes", "may", "plans", "will", "estimate", "continue", "anticipates", "intends", "expects" and similar expressions, constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and forward-looking information within the meaning of applicable Canadian securities laws. All such statements are made pursuant to the "safe harbor" provisions of applicable securities legislation. Forward-looking statements may involve, but are not limited to, comments with respect to our objectives and priorities for the second half of 2008 and beyond, our strategies or future actions, our targets, expectations for our financial condition and the results of, or outlook for, our operations, research, development, product and drug development and our plans and anticipated effects of the transaction described in this press release. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements.

Many such risks, uncertainties and other factors are taken into account as part of our assumptions underlying these forward-looking statements and include, among others, the fol
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
2. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
3. Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
4. Angiotech appoints Hank McKinnell to its Board of Directors
5. Angiotech to participate in Bank of America Health Care Conference
6. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
7. Angiotech elects to suspend Vascular Wrap(TM) pivotal clinical trials
8. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
9. Angiotechs novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
10. Angiotech announces director resignation
11. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013  Continuing its long history of proven ... Beckman Coulter , Inc. announces the U.S. Food and ... AccuTnI+3 troponin I assay for use on its Access ... on Beckman Coulter,s troponin I test for ... the proven performance to continue providing dependability to laboratories ...
(Date:6/19/2013)... India , June 19, ... Bharat Book Bureau presents Innovative ... and Formulation Technology Licensing Opportunities ... http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/innovative-drug-delivery-systems-novel-product-and-formulation-technology-licensing-opportunities-for-generic-pharmaceutical-companies.html ) There ... or controlled release drugs approved ...
(Date:6/19/2013)... Express Diagnostics Int’l, Inc., manufacturer of DrugCheck® ... has received Class III medical device license approval from ... NxStep Onsite Drug Screen Cup in Canada. Class ... in near-patient settings, such as physicians’ offices. , The ... Class III approval for 24 different drugs and detection ...
(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 ... innovation and sustainability, the Consulate General of Switzerland in ... solar boat, Switzerland’s MS Tûranor PlanetSolar , to ... part of its DeepWater Expedition 2013 tour with scientists ... led by Capitain Gérard d’Aboville, runs exclusively on energy ...
Breaking Biology Technology:Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4
... NEW YORK, Dec. 29, 2010 Reportlinker.com ... is available in its catalogue: Molecular ... The technologies that ... fluorescent in situ hybridization (FISH), second-generation biochips ...
... 2010   Today, Gov. Bobby Jindal joined Myriant ... Port of Lake Providence Director Wyly Gilfoil to ... Lake Providence Inc., will soon begin building a ... Providence that will be the world,s largest bio-based ...
... 2010 Market Publishers Ltd informs that new in-demand ... to its catalogue " Drugs & Biotechnology ." ... regularly updated, professional patent search which not only identifies ... by a convenient online interface. ...
Cached Biology Technology:Reportlinker Adds Molecular Diagnostics Markets 2Gov. Jindal Announces Myriant Technologies to Begin Construction of New, Sustainable Specialty Chemical Plant in Lake Providence 2Gov. Jindal Announces Myriant Technologies to Begin Construction of New, Sustainable Specialty Chemical Plant in Lake Providence 3New Topical Patent Research Reports Recently Published at MarketPublishers.com 2New Topical Patent Research Reports Recently Published at MarketPublishers.com 3
(Date:6/18/2013)... of Medicine have discovered a mechanism that is used ... component of blood typically associated with clotting, were discovered ... seal it off from the rest of the body. ... this week, provide the science community with a ... known that platelets do participate in immunity, but now ...
(Date:6/18/2013)... large "dead zone" in the Gulf of Mexico and ... Bay this year, based on several NOAA-supported forecast models. ... State University, and the Louisiana Universities Marine Consortium ... "dead" zone will be between 7,286 and 8,561 square ... recorded. That would range from an area the size ...
(Date:6/18/2013)... Association for Molecular Pathology is proud to announce it ... Biology (FASEB) on July 1, 2013. The FASEB Board ... , The 26 constituent societies of FASEB represent ... for the advancement of research and education in biological ... more important now than ever," said Jennifer L. Hunt, ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4
... impair the ability of ecosystems to perform vital ... sequestrationsays the nation,s largest organization of ecological scientists. ... of America (ESA) outlines strategies that focus on ... and adapt to climate change. "Decision-makers cannot ...
... wisdom, a new study from plant biologists at UC Davis ... proteins across the membranes of chloroplasts, just as they do ... in the January issue of the journal The Plant ... a living cell is to move things across membranes, both ...
... periods do not indicate long-term trends. An assessment of hundreds ... phenomenon today is in fact nothing new," explains Dr. Dorit ... in Israel has been rising and falling over the past ... lowest levels, most of the time below the present-day level. ...
Cached Biology News:Managing ecosystems in a changing climate 2Managing ecosystems in a changing climate 3Green plant transport mystery solved 2The sea level has been rising and falling over the last 2,500 years 2
... The Label IT siRNA Tracker ... Reagent provides a straight forward approach ... of your design, in an efficient ... tracking experiments. Subcellular localization and functional ...
... siRNA Tracker Intracellular Localization Kit with ... forward approach to directly label and ... an efficient yet non-destructive manner, for ... and functional inhibition of target gene ...
... Gasket slide kit (1x 22K gasket/slide) G2534-60003 ... or Gasket slide kit (2x 11K ... slides offered in either 11K or 22K microarray feature ... gaskets are carefully fabricated and batch tested to ensure ...
... self locking design in ice/water bath ... product number, created to easily match ... availability yet, please order under the ... customer service for assistance. ID clarifier: ...
Biology Products: